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	 Selective	oxidation	of	4‐amino‐2‐methyl‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo[g]‐quinoline‐
3‐carbonitrile	 (1)	with	 selenium	 dioxide	 provided,	 4‐amino‐2‐formyl‐5,10‐dioxo‐1,5,10,10a‐
tetrahydrobenzo[g]quinoline‐3‐carbonitrile	 (2).	 The	 one‐pot	 reaction	 of	 compound	 2	 with
ethyl	 cyanoacetate	 and	 thiourea	 in	 ethanol	 yielded	 4‐amino‐2‐(5‐cyano‐6‐oxo‐2‐thioxo‐
1,2,3,6‐tetrahydropyrimidin‐4‐yl)‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo[g]‐quinoline‐
3‐carbonitrile	(3).	The	cycloaddition	reaction	of	chloroacetic	acid	with	compound	3	yielded	7‐
(4‐amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo‐[g]quinolin‐2‐yl)‐3,5‐dioxo‐
3,5‐dihydro‐2H‐thiazolo[3,2‐a]pyrimidine‐6‐carbonitrile	 (4).	 Moreover,	 Ehrlich‐Sachs
condensation	 reaction	 of	 compound	 4	with	 the	 aromatic	 nitroso	 compounds	 5a‐c	 gave	 the
corresponding	 new	 Schiff	 bases	 6a‐c.	 Staudinger's	 ketene‐imine	 cycloaddition	 reaction	 of
compounds	 6a‐c	 with	 chloroacetyl	 chloride	 afforded	 the	 corresponding	 spiro
[chloroazetidinethiazolopyrimidine]	 derivatives,	 7a‐c.	 On	 the	 otherhand,	 cycoladdition
reaction	 of	 thioglycolic	 acid	 with	 Schiff	 bases	 6a‐c	 yielded	 the	 corresponding
spiro[thiazolidinethiazolopyrimidine]	 derivatives,	 8a‐c.	 Structures	 of	 the	 new	 compounds
were	 elucidated	 by	 compatible	 analytical	 and	 spectroscopic	 (IR,	 1H	 NMR	 and	 MS)
measurements.	 Moreover,	 the	 reaction	 mechanisms	 that	 account	 for	 formation	 of	 the
synthesized	compounds	have	been	discussed.	
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1.	Introduction	
	
β‐Lactam	 as	 synthetic	 intermediate	 has	 been	 widely	
recognized	 in	organic	 synthesis	because	 it	 is	 an	active	moiety	
present	 in	 most	 widely	 used	 antibiotics	 such	 as	 penicillin,	
cephalosporins,	 carbapenems,	 nocardicins	 and	 monobactams	
[1].	 In	 addition	 to	 their	 use	 as	 antibiotics,	 β‐lactams	 are	
increasingly	 being	 used	 as	 synthons	 for	 other	 biologically	
important	 molecules	 [2].	 β‐Lactams,	 particularly	 spirocyclic	
derivatives	 have	 been	 found	 to	 act	 as	 cholesterol	 absorption	
inhibitors	(CAI)	[3],	making	them	potentially	useful	compounds	
for	 development	 of	 drugs	 for	 lowering	 the	 high	 level	 of	
cholesterol.		
More	 recently	 the	 enzymatic	 cleavage	 of	 the	 amyloid	
precursor	 protein	 responsible	 for	 the	 pathogenesis	 of	
Alzheimer’s	 disease	 has	 also	 been	 shown	 to	 coupled	 with	
cholesterol	 regulation	 [4].	 β‐Lactams	act	 also	 as	 inhibitors	 for	
thrombin	[5],	human	cytomegalovirus	protease	(HCMV)	[6]	(	a	
β‐herpes	 virus)	 which	 is	 a	 serious	 pathogen	 in	 immune‐
compromised	 individuals	 [7],	 matrix	 metalloprotease	 [8],	
cysteine	protease	[9]	and	human	leukocyte	elastase	(HLE)	[10].	
Spirocyclic	 β‐lactams	 have	 attracted	 attention	 as	 they	 have	
been	shown	to	be	β‐turn	mimetics	[11]	and	precursors	for	α,α‐
disubstituted	 β‐amino	 acids	 [12].	 It	 has	 been	 found	 also	 that	
spiro‐β‐lactams	 act	 as	 poliovirus	 and	 human	 rhinovirus	 3C‐
proteinases	 inhibitors	 [13].	 Some	 other	 biological	 activities	
such	as	antiviral	[13],	antibacterial	 [14],	anti‐tumor	[15],	anti‐
HIV	 [16]	 and	 anti‐inflammatory	 [17]	 have	been	discovered	 to	
be	associated	with	β‐lactams.	
Moreover,	 thiazolidin‐4‐ones	 and	 their	 derivatives	 are	 an	
important	 class	 of	 compounds	 in	 organic	 and	 medicinal	
chemistry.	The	thiazolidin‐4‐one	ring	system	is	a	core	structure	
in	various	synthetic	pharmaceutical	agents,	displaying	a	broad	
spectrum	 of	 biological	 activities	 such	 as,	 antitubercular	 [18],	
antibacterial	 [19],	 anti‐HIV	 [20],	 anti‐inflammatory	 [21],	 anti‐	
histaminic	 [22],	 antifungal	 [23],	 anticancer	 [24]	 and	 analgesic	
[25].	
On	 the	 other	 hand,	 quinolines	 and	 their	 annelated	
derivatives	 are	 of	 particular	 importance	 by	 virtue	 of	 their	
occurrence	in	numerous	natural	products	along	with	their	wide	
ranging	 pharmaceuticals	 applications,	 including	 antimicrobial	
[26],	 antimalarial	 [27],	 antiviral	 [28]	 antitumor	 [29],	
immunomodulatory	 [30],	 local	anesthetic	 [31],	antiarrhythmic	
[31]	 and	 anti‐inflammatory	 activities	 [32].	 Considering	 all	 of	
these	benefits	and	 in	pursuance	 to	our	 interest	 [33‐35]	 in	 the	
chemistry	 of	 polyfunctional	 heterocycles	 with	 enhanced	
biological	 potency,	 it	 is	 very	 interesting	 to	 synthesize	 new	
compounds	 which	 accommodate	 the	 biologically	 active	
quinoline,	spirocyclic	β‐lactam	and/or	spirocyclic	thiazolidin‐4‐
one	moieties,	in	the	same	structure.	
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Scheme	1
	
	
2.	Experimental	
	
2.1.	Instrumentation		
	
Solvents	 were	 purified	 and	 dried	 according	 to	 usual	
procedures.	Melting	points	were	uncorrected	and	recorded	on	
Gallenkamp	 electrothermal	 melting	 point	 apparatus.	 The	
reactions	 were	 monitored	 and	 the	 purity	 of	 products	 was	
controlled	by	Thin	Layer	Chromatography	(TLC)	using	silica	gel	
aluminum	sheets	60F254	(Merck,	Germany).	The	IR	spectra	were	
obtained	 from	 KBr	 disks	 using	 Perkin	 Elmer	 1650	 FT‐IR	
Spectrophotometer	 (USA).	 1H	 NMR	 spectra	 were	 recorded	 on	
Bruker	 AMX‐250	 spectrometer	 (Germany)	 at	 250	 MHz.	 Mass	
spectra	 were	 recorded	 on	 Hewlett	 Packard	 MS	 5988	
Spectrometer	(USA).	Elemental	microanalyses	were	carried	out	
on	 CE	 440	 Elemental	 Analyzer‐Automatic	 Injector	 (Exeter	
Analytical,	Inc.,	USA)	at	Cairo	University,	Cairo,	Egypt.	
	
2.2.	Synthesis	of	4‐Amino‐2‐methyl‐5,10‐dioxo‐1,5,10,10a‐
tetrahydrobenzo[g]quinoline‐3‐carbonitrile	(1)	
	
This	 compound	 was	 prepared	 according	 to	 a	 reported	
method	[33].	M.p.:	271‐272	oC	(EtOH)	(Lit:	270	oC	[33],	EtOH),	
Yield:	75	%.	
	
2.3.	Synthesis	of	4‐Amino‐2‐formyl‐5,10‐dioxo‐1,5,10,10a‐
tetrahydrobenzo[g]quinoline‐3‐carbonitrile	(2)	
	
A	 mixture	 of	 compound	 1	 (2.65	 g,	 0.01	mol)	 and	 freshly	
sublimed	 SeO2	 (1.11	 g,	 0.01	mol)	was	 heated	 under	 reflux	 in	
dry	 1,4‐dioxane	 (50	 mL)	 for	 24	 h.	 The	 reaction	mixture	 was	
filtered	 while	 hot	 and	 the	 filtrate	 was	 cooled	 to	 room	
temperature.	 The	 precipitate	 was	 filtered	 off,	 dried	 and	
recrystallized	 from	methanol	 to	give	compound	2	(Scheme	1).	
Color:	Brown	crystals.	M.p.:	 >	300	 oC.	Yield:	76	%	 (MeOH).	 IR	
(KBr,	 ,	 cm‐1):	 3387,	 3331,	 3286	 (NH2,	 NH),	 3043	 (C‐H,	
aromatic),	 2892	 (C‐H,	 saturated	 methine),	 2785	 (C‐H,	
aldehyde),	2216	(CN),	1710	(HC=O),	1675	(C=O),	1602	(C=C,	
aromatic).	 1H	 NMR	 (250	MHz,	 DMSO‐d6,	 	 ppm):	 3.62	 (s,	 1H,	
O=C‐CH‐NH),	 6.55	 (s,	 2H,	 NH2,	 D2O‐exchangeable),	 7.42‐8.09	
(m,	 4H,	 Ar‐H),	 9.98	 (s,	 1H,	 CHO)	 and	 10.25	 (s,	 1H,	 NH,	 D2O‐
exchangeable).	 MS	 (m/z,	 (%)):	 279	 (25)	 [M+].	 Anal.	 calcd.	 for	
C15H9N3O3	(279.25):	C,	64.52;	H,	3.25;	N,	15.05.	Found:	C,	64.59;	
H,	3.22;	N,	15.01%.	
	
2.4.	Synthesis	of	4‐Amino‐2‐(5‐cyano‐6‐oxo‐2‐thioxo‐1,2,3,6‐
tetrahydropyrimidin‐4‐yl)‐5,10‐dioxo‐1,5,10,10a‐tetrahydro	
benzo[g]quinoline‐3‐carbonitrile	(3)	
	
A	 mixture	 of	 compound	 2	 (2.79	 g,	 0.01	 mol),	
ethylcyanoacetate	(1.13	g,	1.11	mL,	0.01	mol),	thiourea	(0.76	g,	
0.01	mol)	and	sodium	carbonate	(2.2	g,	0.02	mol)	was	refluxed	
in	ethanol	 (50	mL)	 for	24	h.	The	 reaction	mixture	was	cooled	
then	 neutralized	 with	 glacial	 acetic	 acid.	 The	 precipitate	 that	
formed	 was	 collected,	 filtered	 off	 and	 recrystallized	 from	
ethanol	to	give	a	brown	crystalline	product	which	is	proved	to	
be	 compound	3	 (Scheme	1).	Color:	Brown	crystals.	M.p.:	 280‐
282	oC.	Yield:	71	%	(EtOH).	IR	(KBr,	,	cm‐1):	3379,	3329,	3280	
(NH2,	 NH),	 3038	 (C‐H,	 aromatic),	 2895	 (C‐H,	 saturated	
methine),	 2238,	 2213	 (CN),	 1685,	 1666	 (C=O),	 1605	 (C=C,	
aromatic),	 1165	 (C=S).	 1H	 NMR	 (250	MHz,	 DMSO‐d6,	 	 ppm):	
3.61	(s,	1H,	O=C‐CH‐NH),	6.65	(s,	2H,	NH2,	D2O‐exchangeable),	
7.46	‐	8.10	(m,	4H,	Ar‐H),	9.23	(	s,	1H,	NH,	D2O‐exchangeable),	
9.80	(s,	1H,	NH,	D2O‐exchangeable)	and	10.15	(s,	1H,	NH,	D2O‐
exchangeable).	 MS	 (m/z,	 (%)):	 402	 (30)	 [M+].	 Anal.	 calcd.	 for	
C19H10N6O3S	 (402.39):	 C,	 56.71;	 H,	 2.50;	 N,	 20.89;	 S,	 7.97.	
Found:	C,	56.76;	H,	2.48;	N,	20.85;	S,	7.94%.	
	
2.5.	Synthesis	of	7‐(4‐Amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐
tetrahydrobenzo[g]quinolin‐2‐yl)‐3,5‐dioxo‐3,5‐dihydro‐2H‐
thiazolo[3,2‐a]pyrimidine‐6‐carbonitrile	(4)		
	
A	mixture	 of	 compound	3	 (4.02	 g,	 0.01	mol),	 chloroacetic	
acid	 (0.95	 g,	 0.01	 mol)	 and	 fused	 sodium	 acetate	 (2	 g)	 was	
refluxed	for	16	h	in	a	reaction	medium	of	acetic	acid	and	acetic	
anhydride	 (40	mL,	1:1,	v:v).	The	 reaction	mixture	was	 cooled,	
shaked	well	with	cold	water	(50	mL)	and	allowed	to	stand	for	1	
h	 at	 room	 temperature.	 The	 solid	 product	 was	 filtered	 and	
recrystallized	from	methanol	 to	give	compound	4	(Scheme	1).	
Color:	Reddish	brown	crystals.	M.p.:	>	300	oC.		
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Yield:	80	%	(MeOH).	IR	(KBr,	,	cm‐1):	3385,	3328,	3278	(NH2,	
NH),	 3036	 (C‐H,	 aromatic),	 2940,	 2893	 (C‐H,	 aliphatic),	 2235,	
2210	 (CN),	 1719,	 1680	 (C=O),	 1604	 (C=C,	 aromatic),	 1574	
(C=N,	cyclic).	1H	NMR	(250	MHz,	DMSO‐d6,		ppm):	3.60	(s,	1H,	
O=C‐CH‐NH),	 3.74	 and	 4.00	 (two	 douplets,	 each	 with	 1,2JHH	 =	
15.8	Hz,	2H,	cyclic	methylenes	S‐CH2‐CO],	6.69	(s,	2H,	NH2,	D2O‐
exchangeable),	 7.43‐8.11	 (m,	 4H,	 Ar‐H)	 and	 9.96	 (s,	 1H,	 NH,	
D2O‐exchangeable).	MS	(m/z,	 (%)):	442	(15)	[M+,].	Anal.	calcd.	
for	 C21H10N6O4S	 (442.41):	 C,	 57.01;	 H,	 2.28;	 N,	 19.00;	 S,	 7.25.	
Found:	C,	56.96;	H,	2.31;	N,	19.05;	S,	7.22%.	
	
2.6.	General	Procedure	for	the	Synthesis	of	Schiff	Base	
derivatives	(6a‐c)	
	
A	 mixture	 of	 compound	 4	 (4.42	 g,	 0.01	 mol)	 and	 the	
appropriate	 aromatic	 nitroso	 compound	5a‐c	 (0.01	mol)	 was	
refluxed	 in	 absolute	 ethanol	 for	 10‐12	 h	 in	 the	 presence	 of	 a	
few	 drops	 of	 piperidine.	 The	 reaction	 mixture	 was	 filtered	
while	 hot	 and	 the	 filtrate	 was	 concentrated	 and	 cooled.	 The	
solid	product	was	filtered	off	and	recrystallized	from	ethanol	to	
give	the	Schiff	base	derivatives	6a‐c	(Scheme	2).	
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7‐(4‐Amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo	
[g]quinolin‐2‐yl)‐2‐(1‐hydroxynaphthalen‐2‐ylimino)‐3,5‐dioxo‐
3,5‐dihydro‐2H‐thiazolo[3,2‐a]pyrimidine‐6‐carbonitrile	 (6a):	
Color:	 Purple	 crystals.	M.P.:	 >	 300	 oC.	 Yield:	 79	%	 (EtOH).	 IR	
(KBr,	 ,	 cm‐1):	 3445‐3260	 (OH,	 NH2,	 NH),	 3066,	 3032	 (C‐H,	
aromatic),	 2890	 (C‐H,	 saturated	methine),	 2235,	 2212	 (CN),	
1715,	1680	(C=O),	1645	(C=N,	exocylic),	1608	(C=C,	aromatic),	
1572	(C=N,	cyclic).	 1H	NMR	(250	MHz,	DMSO‐d6,		ppm):	3.61	
(s,	1H,	O=C‐CH‐NH),	6.79	(s,	2H,	NH2,	D2O‐exchangeable),	7.25‐
8.11	 (m,	 11H,	 Ar‐H	 and	 OH)	 and	 10.23	 (s,	 1H,	 NH,	 D2O‐
exchangeable).	MS	 (m/z,	 (%)):	 597	 (16)	 [M+].	 Anal.	 calcd.	 for	
C31H15N7O5S	 (597.56):	 C,	 62.31;	 H,	 2.53;	 N,	 16.41;	 S,	 5.37.	
Found:	C,	62.26;	H,	2.55;	N,	16.37;	S,	5.34%.	
7‐(4‐Amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo	
[g]quinolin‐2‐yl)‐2‐(4‐hydroxy‐phenylimino)‐3,5‐dioxo‐3,5‐
dihydro‐2H‐thiazolo[3,2‐a]pyrimidine‐6‐carbonitrile	(6b):	Color:	
Reddish	brown	crystals.	M.p.:	>	300	oC.	Yield:	81	%	(EtOH).	IR	
(KBr,	 ,	 cm‐1):	 3435‐3250	 (OH,	 NH2,	 NH),	 3062,	 3025	 (C‐H,	
aromatic),	 2890	 (C‐H,	 saturated	methine),	 2238,	 2216	 (CN),	
1713,	1682	(C=O),	1645	(C=N,	exocylic),	1605	(C=C,	aromatic),	
1570	(C=N,	cyclic).	 1H	NMR	(250	MHz,	DMSO‐d6,		ppm):	3.62	
(s,	1H,	O=C‐CH‐NH),	6.77	(s,	2H,	NH2,	D2O‐exchangeable),	7.04‐
8.14	 (m,	 9H,	 Ar‐H	 and	 OH),	 10.25	 (s,	 1H,	 NH,	 D2O‐
exchangeable).	MS	 (m/z,	 (%)):	 547	 (20)	 [M+].	 Anal.	 calcd.	 for	
C27H13N7O5S	 (547.50):	 C,	 59.23;	 H,	 2.39;	 N,	 17.91;	 S,	 5.86.	
Found:	C,	59.19;	H,	2.41;	N,	17.87;	S,	5.88%.	
7‐(4‐Amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo	
[g]quinolin‐2‐yl)‐2‐(4‐(dimethylamino)phenylimino)‐3,5‐dioxo‐
3,5‐dihydro‐2H‐thiazolo[3,2‐a]pyrimidine‐6‐carbonitrile	 (6c):	
Color:	 Brown	 crystals.	 M.p.:	 >	 300	 oC.Yield:	 84	 %	 (EtOH).	 IR	
(KBr,	,	 cm‐1):	 3374,	 3319,	 3277	 (NH2,	NH),	 3062,	 3025	 (C‐H,	
aromatic),	2890,	2860,	2810	(C‐H,	aliphatic),	2237,	2213	(CN),	
1710,	1680	(C=O),	1644	(C=N,	exocylic),	1605	(C=C,	aromatic),	
1573	(C=N,	cyclic).	 1H	NMR	(250	MHz,	DMSO‐d6,		ppm):	2.84	
(s,	 6H,	 ‐N(CH3)2),	 3.62	 (s,	 1H,	 O=C‐CH‐NH),	 6.73	 (s,	 2H,	 NH2,	
D2O‐exchangeable),	 6.91‐8.15	 (m,	8H,	Ar‐H),	 10.19	 (s,	 1H,	NH,	
D2O‐exchangeable).	MS	 (m/z,	 (%)):	574	 (25)	 [M+].	Anal.	 calcd.	
for	 C29H18N8O4S	 (574.57):	 C,	 60.62;	 H,	 3.16;	 N,	 19.50;	 S,	 5.58.	
Found:	C,	60.65;	H,	3.15;	N,	19.48;	S,	5.57%.	
	
2.7.	General	procedure	for	synthesis	of	the	spiro[chloro	
azetidinethiazolopyrimidine]	derivatives	(7a‐c)		
	
To	a	mixture	of	the	appropriate	Schiff	base	derivative	6a‐c	
(0.01	 mol)	 and	 triethylamine	 (1.4	 mL,	 0.01	 mol)	 in	 dry	 1,4‐
dioxane	 (40	 mL),	 chloroacetyl	 chloride	 (1.13	 g,	 0.8	 mL,	 0.01	
mol)	 was	 added	 drop	 wise	 at	 room	 temperature.	 After	
completion	 of	 addition,	 the	 reaction	 mixture	 was	 stirred	 for	
further	 48	 h.	 The	 formed	 triethylamine	 hydrochloride	 was	
removed	 by	 filtration	 and	 washed	 well	 with	 dioxane.	 After	
removal	of	the	volatile	materials	from	the	filtrate	in	vacuum,	a	
mixture	of	ice‐cold	water	was	added	to	the	residue.	The	formed	
solid	 product	was	 filtered	 off,	 washed	 thoroughly	with	water	
and	 recrystallized	 from	 the	appropriate	 solvent	 to	 give	 finally	
the	 spiro[chloroazetidinethiazolopyrimidine]	 derivatives	 7a‐c	
(Scheme	2).	
7'‐(4‐Amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo	
[g]quinolin‐2‐yl)‐3‐chloro‐1‐(1‐hydroxynaphthalen‐2‐yl)‐3',4,5'‐
trioxo‐3',5'‐dihydrospiro[azetidine‐2,2'‐thiazolo[3,2‐a]	
pyrimidine]‐6'‐carbonitrile	 (7a):	Color:	 Brown	 crystals.	M.p.:	 >	
300	 oC	 (EtOH).	Yield:	78	%.	 IR	(KBr,	,	 cm‐1):	3440‐3250	(OH,	
NH2,	 NH),	 3062,	 3025	 (C‐H,	 aromatic),	 2930,	 2890	 (C‐H,	
saturated	methine),	2235,	2207	(CN),	1713,	1685	(C=O),	1609	
(C=C,	 aromatic),	 1577	 (C=N,	 cyclic),	 627	 (C‐Cl,	 aliphatic).	 1H	
NMR	 (250	 MHz,	 DMSO‐d6,	 	 ppm):	 3.61	 (s,	 1H,	 O=C‐CH‐NH),	
5.46	 (s,	1H,	Cl‐CH),	6.66	 (s,	 2H,	NH2,	D2O‐exchangeable),	7.02‐
8.13	 (m,	 11H,	 Ar‐H	 and	 OH),	 10.21	 (s,	 1H,	 NH,	 D2O‐
exchangeable).	MS	(m/z,	(%)):	673	(30)	[M+,	35Cl],	675	(9)	[M+,	
37Cl].	Anal.	calcd.	for	C33H16ClN7O6S	(674.05):	C,	58.80;	H,	2.39;	
N,	14.55;	S,	4.76.	Found:	C,	58.78;	H,	2.40;	N,	14.52;	S,	4.78%.	
7'‐(4‐Amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo	
[g]quinolin‐2‐yl)‐3‐chloro‐1‐(4‐hydroxyphenyl)‐3',4,5'‐trioxo‐
3',5'‐dihydrospiro[azetidine‐2,2'‐thiazolo[3,2‐a]	 pyrimidine]‐6'‐
carbonitrile	(7b):	Color:	Reddish	brown	crystals.	M.p.:	279‐280	
oC.	Yield:	82	%	(MeOH).	IR	(KBr,	,	cm‐1):	3430‐3250	(OH,	NH2,	
NH),	 3062,	 3025	 (C‐H,	 aromatic),	 2930,	 2890	 (C‐H,	 saturated	
methine),	 2237,	 2209	 (CN),	 1710,	 1680	 (C=O),	 1607	 (C=C,	
aromatic)	and	1575	(C=N,	cyclic),	629	(C‐Cl,	aliphatic).	1H	NMR	
(250	MHz,	DMSO‐d6,		ppm):	3.60	(s,	1H,	O=C‐CH‐NH),	5.44	(s,	
1H,	Cl‐CH),	6.68	 (s,	2H,	NH2,	D2O‐exchangeable),	7.01‐8.13	(m,	
9H,	 Ar‐H	 and	 OH),	 10.18	 (s,	 1H,	 NH,	 D2O‐exchangeable).	 MS	
(m/z,	 (%)):	623	 (25)	 [M+,	 35Cl],	 625	 (7)	 [M+,	 37Cl].	 Anal.	 calcd.	
for	C29H14ClN7O6S	(623.99):	C,	55.82;	H,	2.26;	N,	15.71;	S,	5.14.	
Found:	C,	55.87;	H,	2.23;	N,	15.68;	S,	5.12%.		
7'‐(4‐Amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo	
[g]quinolin‐2‐yl)‐3‐chloro‐1‐(4‐(dimethylamino)phenyl)‐3',4,5'‐
trioxo‐3',5'‐dihydrospiro[azetidine‐2,2'‐thiazolo[3,2‐a]	
pyrimidine]‐6'‐carbonitrile	 (7c):	 Color:	 Green	 crystals.	 M.p.:	 >	
300	oC.	Yield:	79	%	(MeOH).	IR	(KBr,	,	cm‐1	):	3381,	3329,	3277	
(NH2,	NH),	3062,	3025	(C‐H,	aromatic),	2930,	2890,	2860,	2810	
(C‐H,	 aliphatic),	 2238,	 2210	 (CN),	 1706,	 1675	 (C=O),	 1607	
(C=C,	 aromatic),	 1575	 (C=N,	 cyclic),	 624	 (C‐Cl,	 aliphatic).	 1H	
NMR	(250	MHz,	DMSO‐d6,		ppm):	2.82	(s,	6H,	‐N(CH3)2),	3.60	
(s,	1H,	O=C‐CH‐NH),	5.50	(s,	1H,	Cl‐CH),	6.65	(s,	2H,	NH2,	D2O‐
exchangeable),	6.94‐8.14	(m,	8H,	Ar‐H),	10.13	(s,	1H,	NH,	D2O‐
exchangeable).	MS	(m/z,	 (%)):	650	(20)	[M+,	35Cl]	and	652	(6)	
[M+,	 37Cl].	Anal.	 calcd.	 for	C31H19ClN8O5S	 (651.06):	C,	 57.19;	H,	
2.94;	 N,	 17.21;	 S,	 4.92.	 Found:	 C,	 57.15;	 H,	 2.96;	 N,	 17.18;	 S,	
4.94%.		
	
2.8.	General	Procedure	for	synthesis	of	the	spiro[thiazolidine	
thiazolopyrimidine]	derivatives	(8a‐c)	
	
A	 mixture	 of	 the	 appropriate	 Schiff	 base	 derivative	 6a‐c	
(0.01	mol)	and	thioglycolic	acid	(0.92	g,	0.01	mol)	was	refluxed	
in	dry	benzene	(50	mL)	 for	24	h.	After	removal	of	 the	volatile	
materials	 under	 reduced	pressure,	 an	 ice	 ‐cold	water	mixture	
was	 added	 to	 the	 residue.	 The	 formed	 solid	 product	 was	
filtered	 off,	 washed	 thoroughly	 with	 water,	 dried	 and	
recrystallized	 from	 the	 appropriate	 solvent	 to	 give	 the	
spiro[thiazolidinethiazolopyrimidine]	 derivatives	 8a‐c	
(Scheme	2).	
7'‐(4‐Amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo	
[g]quinolin‐2‐yl)‐3‐(1‐hydroxynaphthalen‐2‐yl)‐3',4,5'‐trioxo‐
3',5'‐dihydrospiro[thiazolidine‐2,2'‐thiazolo[3,2‐a]pyrimidine]‐
6'‐carbonitrile	(8a):	Color:	Brown	crystals.	M.p.:	>	300	oC.	Yield:	
80	%	(EtOH).	IR	(KBr,	,	cm‐1):	3430‐3240	(OH,	NH2,	NH),	3062,	
3025	(C‐H,	aromatic),	2940,	2893	(C‐H,	aliphatic),	2239,	2214	
(CN),	 1717,	 1680	 (C=O),	 1610	 (C=C,	 aromatic),	 1571	 (C=N,	
cyclic).	1H	NMR	(250	MHz,	DMSO‐d6,		ppm):	3.61	(s,	1H,	O=C‐
CH‐NH),	3.76	and	4.02	(two	doublets	each	with	1,2JHH	=	16.2	Hz,	
2H,	 cyclic	 methylenes,	 S‐CH2‐C=O),	 6.74	 (s,	 2H,	 NH2,	 D2O‐
exchangeable),	7.01‐8.14	(m,	11H,	Ar‐H	and	OH),	10.19	(s,	1H,	
NH,	 D2O‐exchangeable).	 MS	 (m/z,	 (%)):	 671	 (15)	 [M+].	 Anal.	
calcd.	for	C33H17N7O6S2	(671.66):	C,	59.01;	H,	2.55;	N,	14.60;	S,	
9.55.	Found:	C,	59.07;	H,	2.53;	N,	14.57;	S,	9.52%.	
7'‐(4‐Amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo	
[g]quinolin‐2‐yl)‐3‐(4‐hydroxyphenyl)‐3',4,5'‐trioxo‐3',5'‐dihydro	
spiro[thiazolidine‐2,2'‐thiazolo[3,2‐a]pyrimidine]‐6'‐carbonitrile	
(8b):	Color:	Reddish	brown	crystals.	M.p.:	>	300	oC.	Yield:	78	%	
(MeOH).	 IR	 (KBr,	 ,	 cm‐1):	 3440‐3240	 (OH,	 NH2,	 NH),	 3057,	
3025	(C‐H,	aromatic),	2940,	2893	(C‐H,	aliphatic),	2234,	2210	
(CN),	 1710,	 1680	 (C=O),	 1608	 (C=C,	 aromatic),	 1572	 (C=N,	
cyclic).	1H	NMR	(250	MHz,	DMSO‐d6,		ppm):	3.61	(s,	1H,	O=C‐
CH‐NH),	3.76	and	4.03	(two	doublets	each	with	1,2JHH	=	16.0	Hz,	
2H,	 cyclic	 methylenes	 S‐CH2‐C=O),	 6.70	 (s,	 2H,	 NH2,	 D2O‐
exchangeable),	 7.01‐8.14	 (m,	 9H,	 Ar‐H	 and	 OH),	 10.15	 (s,	 1H,	
NH,	 D2O	 exchangeable).	 MS	 (m/z,	 (%)):	 621	 (20)	 [M+].	 Anal.	
calcd.	for	C29H15N7O6S2	(621.60):	C,	56.04;	H,	2.43;	N,	15.77;	S,	
10.32.	Found:	C,	55.98;	H,	2.44;	N,	15.80;	S,	10.35%.	
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Scheme	3
	
	
7'‐(4‐Amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo	
[g]quinolin‐2‐yl)‐3‐(4‐(dimethylamino)phenyl)‐3',4,5'‐trioxo‐3',	
5'‐dihydrospiro[thiazolidine‐2,2'‐thiazolo[3,2‐a]	 pyrimidine]‐6'‐
carbonitrile	(8c):	Color:	Brown	crystals.	M.p.:	>	300	oC.	Yield:	87	
%	(EtOH).	IR	(KBr,	,	cm‐1):	3373,	3333,	3275	(NH2,	NH),	3059,	
3027	(C‐H,	aromatic),	2940,	2893,	2860,	2810	(C‐H,	aliphatic),	
2237,	2210	(CN),	1705,	1675	(C=O),	1608	(C=C,	aromatic)	and	
1572	(C=N,	cyclic).	 1H	NMR	(250	MHz,	DMSO‐d6,		ppm):	2.82	
(s,	6H,	‐N(CH3)2),	3.61	(s,	1H,	O=C‐CH‐NH	),	3.75	and	4.01	(two	
doublets	 each	with	 1,2	 JHH	 =	 16.1	 Hz,	 2H,	 cyclic	methylenes	 S‐
CH2‐C=O),	 6.64	 (s,	 2H,	 NH2,	 D2O‐exchangeable),	 6.89‐8.12	 (m,	
8H,	Ar‐H),	10.11	(s,	1H,	NH,	D2O‐exchangeable).	MS	(m/z,	(%)):	
648	(18)	[M+].	Anal.	calcd.	for	C31H20N8O5S2	(648.67):	C,	57.40;	
H,	3.11;	N,	17.27;	S,	9.88.	Found:	C,	57.46;	H,	3.09;	N,	17.25;	S,	
9.92%.		
	
3.	Results	and	discussion	
	
It	 has	 been	 now	 found	 that	 selective	 oxidation	 [36]	 of	 4‐
amino‐2‐methyl‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenz[g]	
quinoline‐3‐carbonitrile	 (1)	 [33]	 with	 freshly	 sublimed	
selenium	 dioxide	 in	 dry	 1,4‐dioxane	 gave	 4‐amino‐2‐formyl‐
5,10‐dioxo‐1,5,10,10a‐tetrahydrobenz[g]‐quinoline‐3‐carbo‐
nitrile	 (2)	 as	 brown	 crystals	 in	 yield	 of	 76%	 (Scheme	 1).	
Correct	 elementary	and	molecular	weight	determination	 (MS)	
for	 compound	2	corresponded	 to	C15H9N3O3	 (MS:	 [M+]	 at	m/z	
279).	Its	IR	spectrum	showed	strong	absorption	bands	at	2785	
and	1710	cm‐1	due	to	C–H	and	C=O	bonds,	respectively,	of	 the	
formed	 aldehyde	 group.	 The	 IR	 spectrum	 showed	 also	
absorption	bands	at	3387,	3331,	3286	(NH2	and	NH),	3043	(C–
H,	 aromatic),	 2892	 (C‐H,	 saturated	methine),	 2216	 (CN)	 and	
1675	(C=O).	The	1H	NMR	spectrum	of	compound	2	 lacked	any	
absorption	 due	 to	 methyl	 group	 protons	 which	 appeared	
around	 	 2.43	 ppm	 in	 the	 1H	 NMR	 spectrum	 of	 compound	1	
[33].	On	the	other	hand,	the	1H	NMR	spectrum	of	compound	2	
showed	a	singlet	at	9.98	ppm	which	is	attributed	to	the	proton	
of	the	aldehyde	group	[37].	Moreover,	the	singlet	that	appeared	
at	3.62	ppm	is	attributed	to	the	methine	proton	O=C‐CH‐NH	on	
the	 saturated	 sp3	 carbon	 atom	 in	 the	 benzoquinoline	 moiety.	
The	 spectrum	 showed	 also	 signals	 at	 6.55	 (s,	 2H,	 NH2,	 D2O‐
exchangeable),	 7.42‐8.09	 (m,	 4H,	 aromatic)	 and	 10.25	 (s,	 1H,	
NH,	D2O‐exchangeable).	
The	 one–pot	 reaction	 of	 compound	 2	 with	
ethylcyanoacetate	and	thiourea	in	ethanol	with	the	presence	of	
sodium	 carbonate	 gave	 4‐amino‐2‐(5‐cyano‐6‐oxo‐2‐thioxo‐
1,2,3,6‐tetrahydro‐pyrimidin‐4‐yl)‐5,10‐dioxo‐1,5,10,10a‐
tetrahydrobenzo[g]‐	quinoline‐3‐carbonitrile	 (3)	where	a	new	
substituted	 tetrahydropyrimidine	 ring	 has	 been	 formed	
(Schemes	 1	 and	 3).	 A	 postulated	 reaction	 mechanism	 that	
accounts	 for	 the	 formation	 of	 compound	 3	 is	 represented	 in	
Scheme	3.	 The	 carbanion	which	 is	 generated	 from	ethylcyano	
acetate,	 in	 presence	 of	 sodium	 carbonate,	 undergoes	 a	
nucleophilic	attack	on	the	aldehydic	carbon	atom	of	compound	
2	 to	give	an	 intermediate	 like	A	with	subsequent	dehydration	
process	 to	 eliminate	 a	 water	 molecule	 (Scheme	 3).	 Such	
addition‐elimination	processes	resulted	in	the	formation	of	the	
cyanoacrylate	 intermediate	 B	 (Scheme	 3).	 A	 second	
nucleophilic	 attack	 by	 the	 NH2	 group	 of	 thiourea	 on	 the	
carbonyl	ester	 group	 followed	by	an	elimination	of	an	alcohol	
molecule	 gave	 the	 intermediate	 C	 (Scheme	 3).	 An	
intramolecular	 heterocyclization	 of	 C	 gave	 intermediate	 D	
which	undergoes	a	spontaneous	auto	oxidation	process	[38,39]	
with	 an	 elimination	 of	 a	 hydrogen	molecule	 to	 give	 finally	 4‐
amino‐2‐(5‐cyano‐6‐oxo‐2‐thioxo‐1,2,3,6‐tetrahydropyrimidin‐
4‐yl)‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo[g]quinoline‐3‐
carbonitrile	(3)	(Schemes	1	and	3).	
The	 chemical	 structure	 of	 compound	 3	 was	 confirmed	
through	 its	 elemental	 analysis	 and	 mass	 spectrometry	
measurement	 ([M]+	 at	 m/z	 402),	 which	 corresponded	 to	
C19H10N6O3S.	 The	 IR	 spectrum	 of	 compound	 3	 showed	 an	
absorption	 band	 at	 1165	 cm‐1	 due	 to	 the	 exocyclic	 C=S	 bond	
[37].	 The	 spectrum	 revealed	 the	 absence	 of	 the	 aldehyde	
carbonyl	group	absorption	band	that	appeared	 in	spectrum	of	
compound	2	at	1710	cm‐1.	However,	 it	showed	bands	at	2238,	
2213	 and	 1685,	 1666	 cm‐1	 due	 to	 the	 absorption	 of	 CN	 and	
C=O	groups,	respectively.		
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Scheme	4
	
	
The	 1H	 NMR	 spectrum	 of	 compound	 3	 revealed	 the	
presence	 of	 four	 signals	 at	 6.65,	 9.23,	 9.80	 and	 10.15	 ppm	
where	 all	 were	 found	 to	 be	 D2O‐exchangeable.	 These	 signals	
were	attributed	to	the	five	protons	bonded	to	the	four	nitrogen	
atoms	in	compound	3.	The	singlet	that	appeared	at	3.61	ppm	is	
attributed	 to	 the	 methine	 proton	 O=C‐CH‐NH	 on	 the	 sp3	
saturated	 carbon	 atom	 in	 the	 benzoquinoline	 moiety.	
Moreover,	the	spectrum	lacked	any	other	absorption	bands	due	
to	protons	on	saturated	carbon	atoms.	
Moreover,	 compound	 3	 reacted	 with	 chloroacetic	 acid	 in	
presence	of	 fused	sodium	acetate	and	acetic	acid	 to	give	7‐(4‐
amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo‐[g]	
quinolin‐2‐yl)‐3,5‐dioxo‐3,5‐dihydro‐2H‐thiazolo[3,2‐a]pyrimi‐
dine‐6‐carbonitrile	 (4)	 as	 reddish	brown	crystals	 in	 a	yield	of	
80%	(Schemes	1	and	4).		
A	 suggested	 mechanism	 for	 formation	 of	 compound	 4	 is	
depicted	in	Scheme	4.	Thus,	the	reaction	apparently	involves	a	
nucleophilic	attack	by	the	sulphur	atom	of	compound	3	on	the	
chlorine‐bearing	 carbon	 atom	 of	 chloroacetic	 acid	 to	 give	 an	
intermediate	 F	 through	 a	 transition	 state	 like	 E	 with	
elimination	 of	 acetic	 acid	 and	 sodium	 chloride	 molecules	
(Scheme	 4).	 Intermediate	 F	 undergoes	 an	 intramolecular	
heterocyclization	 reaction	 with	 an	 elimination	 of	 a	 water	
molecule	to	give	finally	compound	4	(Schemes	1	and	4).		
Compound	 4	 was	 given	 the	 assigned	 structure	 for	 the	
following	reasons:		
a)	 Molecular	 weight	 determination	 for	 compound	 4	
corresponds	to	C21H10N6O4S	(442.41).	
b)	 Its	mass	spectrum	showed	the	molecular	 ion	peak	 [M+]	
at	m/z	442.	
c)	 The	 IR	 spectrum	 of	 compound	 4	 showed	 absorption	
bands	at	3385,	3328,	3278	cm‐1	due	to	‐NH2	and	NH	groups.	
It	 showed	also	bands	at	3036	(C‐H,	aromatic),	2940,	2893	
(C‐H,	 aliphatic),	 2235,	 2210	 (CN),	 1719,	 1680	 (C=O)	 and	
1574	(C=N,	cyclic).	Moreover,	absorption	due	to	C=S	group	
which	appeared	around	1165	cm‐1	 in	the	IR	spectrum	of	3	
has	disappeared	in	that	of	compound	4.	
d)	 The	 1H	 NMR	 spectrum	 revealed	 the	 presence	 of	 two	
doublets	 at	 	 3.74	 ppm	 and	 4.00	 ppm	 (each	with	 1,2JHH	 =	
15.8	 Hz)	 due	 to	 the	 geminal	 methylene	 protons	 in	 the	
formed	 fused	 thiazolidinone	 ring.	 These	 two	 protons	 are	
chemically	 equivalent	 but	 magnetically	 non‐equivalent,	
therefore,	they	coupled	with	each	other	[37].		
The	spectrum	showed	only	two	signals	due	to	absorption	of	
protons	 on	 nitrogen	 at	 δ	 6.69	 ppm	 (s,	 2H,	 NH2,	 D2O‐
exchangeable)	 and	 9.96	 ppm	 (s,	 1H,	 NH,	 D2O‐exchangeable).	
The	 aromatic	 protons	 appeared	 as	 a	 multiplet	 in	 the	 region	
7.43‐8.11	ppm	(4H).	
Schiff	 bases	 represent	 a	 very	 important	 class	 of	 organic	
compounds	 because	 of	 their	 applications	 in	 many	 fields,	
including	 biological,	 inorganic	 and	 analytical	 chemistry	 [40].	
They	are	usually	prepared	by	condensing	primary	amines	with	
aldehydes	 or	 ketones	 where	 one	 or	 both	 of	 the	 reactants	 is	
aromatic	 [40].	 However,	 an	 alternative	 method	 for	 the	
synthesis	 of	 Schiff	 bases	 is	 Ehrlich‐Sachs	 reaction	 [41,42]	
where	 the	 imino	 group	 is	 formed	 by	 nitrosation	 at	 a	 carbon	
bearing	 active	methylene	hydrogen	 atoms.	Thus,	 compound	4	
reacted	with	the	aromatic	nitroso	derivatives	5a‐c	 in	absolute	
ethanol	under	reflux	with	the	presence	of	piperidine	to	give	the	
corresponding	 new	 Schiff	 base	 derivatives	 6a‐c	 (Scheme	 2).	
Structural	reasoning	for	7‐(4‐amino‐3‐cyano‐5,10‐dioxo‐1,5,10,	
10a‐tetrahydrobenzo[g]	 quinolin‐2‐yl)‐2‐(4‐(dimethyl	 amino)	
phenylimino)‐3,5‐dioxo‐3,5‐dihydro‐2H‐thiazolo[3,2‐a]	
pyrimidine‐6‐carbonitrile	 (6c),	 taken	 as	 a	 representative	
example,	are:	
a)	 Elemental	 analysis	 of	 compound	 6c	 corresponds	 to	 a	
molecular	formula	of	C29H18N8O4S	(574.57).	
b)	Its	mass	spectrum	recorded	the	molecular	ion	peak	[M]+	
at	m/z	574.	
c)	Its	IR	Spectrum	showed	absorption	bands	at	3374,	3319	
and	 3277	 (NH2,	 NH),	 3062,	 3025	 (C‐H,	 aromatic),	 2890,	
2860,	2810	(C‐H,	aliphatic),	2237,	2213	(CN),	1710,	1680	
(C=O),	 1644	 (C=N,	 exocyclic),	 1605	 (C=C,	 aromatic)	 and	
1573	(C=N,	cyclic).	
d)	 The	 1H	 NMR	 spectrum	 of	 compound	 6c	 lacked	 any	
signals	due	to	the	two	methylene	protons	which	appeared	
in	that	of	compound	4	at	3.74	and	4.00	ppm.	However,	the	
spectrum	 showed	 a	 singlet	 at	 2.84	 ppm	 due	 to	 the	 six	
protons	 of	 two	methyl	 groups	 on	 nitrogen.	 The	 spectrum	
revealed	also	the	presence	of	signals	at	3.62	(s,	1H,	O=C‐CH‐
NH),	6.73	(s,	2H,	NH2,	D2O‐exchangeable),	6.91‐8.15	(m,	8H,	
aromatic	 protons)	 and	 10.19	 (s,	 1H,	 NH,	 D2O‐
exchangeable).		
Among	the	several	methods	for	the	synthesis	of	β‐lactams,	
the	 cycloaddition	 reaction	 of	 Schiff	 bases	 with	 ketenes	
(Staudinger	 reaction)	 [43,44]	 is	 mostly	 applied.	 This	 method	
has	 been	 used	 for	 the	 synthesis	 of	 a	 large	 number	 of	
monocyclic,	bicyclic,	tricyclic	and	spirocyclic	β‐lactams	[1].	The	
α‐methylene	protons	in	chloroacetyl	chloride	are	activated	due	
to	the	electron‐withdrawing	inductive	effect	(‐I)	effect	exerted	
by	 the	 adjacent	 chlorine	 atom	 and	 the	 carbonyl	 group.	
Therefore,	 in	 presence	 of	 triethylamine,	 chloroacetyl	 chloride	
loses	 a	 hydrogen	 chloride	 molecule	 to	 give	 the	 ketene	
ClHC=C=O	[45].		
Although	commonly	described	as	a	[2 +2]	cycloaddition,	it	is	
generally	accepted	that	Staudinger	reaction	 is	 in	 fact	stepwise	
[46,47].	Thus,	the	cycloaddition	reaction	of	compounds	6	with	
chloroacetyl	 chloride	 (Scheme	 2)	 involves,	 in	 its	 first	 step,	 a	
nucleophilic	attack	by	nitrogen	atom	of	the	polarized	exocyclic	
imino	group	on	the	sp‐hybridized	carbon	of	the	ketene,	which	is	
formed	 in	 situ,	 to	 form	 a	 zwitterionic	 intermediate	 like	 H	
through	 the	 transition	 state	 G.	 In	 the	 second	 step,	 intra‐
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molecular	 cyclization	 of	 intermediate	 H	 forms	 the	 spiro‐
azetidinone	 ring	 giving	 compounds	 7a‐c	 (Scheme	 2).	 The	
substituents	 present	 in	 the	 imines	 or	 the	 acid	 chlorides,	 the	
nature	of	bases/solvents,	the	reaction	conditions	and	even	the	
order	of	addition	of	the	reagents	have	been	found	to	affect	the	
formation	of	the	azetidinone	ring	as	well	as	its	stereochemistry	
[46,47].		
The	 mass	 spectrum	 of	 7'‐(4‐amino‐3‐cyano‐5,10‐dioxo‐
1,5,10,10a‐tetrahydrobenzo[g]quinolin‐2‐yl)‐3‐chloro‐1‐(4‐
(dimethylamino)phenyl)‐3',4,5'‐trioxo‐3',5'‐dihydrospiro‐	
[azetidine‐2,2'‐thiazolo[3,2‐a]pyrimidine]‐6'‐carbonitrile	 (7c),	
taken	as	a	representative	example,	recorded	the	molecular	ion	
peak	 [M]+	 at	m/z	 650	 (based	on	 35Cl)	 and	m/z	 652	 (based	on	
37Cl)	 which	 corresponds	 to	 C31H19ClN8O5S.	 Its	 IR	 spectrum	
showed	 no	 absorption	 band	 due	 to	 the	 exocyclic	 C=N	 which	
appeared	 for	 compound	 6c	 at	 1644	 cm‐1.	 This	 indicates	 the	
saturation	 of	 such	 bond	 due	 to	 addition.	 Moreover,	 the	
spectrum	showed	strong	bands	at	2930,	2890,	2860,	2810	cm‐1	
due	to	the	aliphatic	C‐H	bonds	and	at	624	cm‐1	due	to	C‐Cl	bond	
[37].	 The	 spectrum	 showed	 also	 absorption	 bands	 at	 3381,	
3329,	3277	(NH2,	NH),	3062,	3025	(C‐H,	aromatic),	2238,	2210	
(CN),	1706,	1675	(C=O),	1607	(C=C,	aromatic)	and	1575	(C=N,	
cyclic).	 In	the	1H	NMR	spectrum	of	compound	7c,	 the	methine	
proton	on	the	carbon‐bearing	chlorine	appeared	as	a	singlet	at	
	 5.50	 ppm.	 The	 singlet	 that	 appeared	 at	 2.82	 ppm	 was	
attributed	 to	 protons	 (6H)	 of	 the	 two	 methyl	 groups	 on	
nitrogen.	The	spectrum	revealed	also	the	presence	of	bands	at	
3.60	(s,	1H,	O=C‐CH‐NH),	6.65	(s,	2H,	NH2,	D2O‐exchangeable),	
6.94‐8.14	(m,	8H,	aromatic	protons)	and	10.13	(s,	1H,	NH,	D2O‐
exchangeable).		
Moreover,	 the	 imino	 group	 of	 Schiff	 base	derivatives	6a‐c	
could	 be	 utilized	 also	 to	 form	 a	 new	 thiazolidin‐4‐one	 ring.	 A	
conventional	method	for	thiazolidin‐4‐one	ring	formation	is	the	
heterocyclization	 of	 imino	 groups	 with	 thioglycolic	 acid	
[18,20].	Thus,	when	Schiff	base	derivatives	6a‐c	were	refluxed	
in	 benzene	 with	 thioglycolic	 acid	 the	 corresponding	 7'‐(4‐
amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetrahydrobenzo[g]	
quinolin‐2‐yl)‐3‐(aryl)‐3',4,5'‐trioxo‐3',5'‐dihydrospiro	
[thiazolidine‐2,2'‐thiazolo[3,2‐a]pyrimidine]‐6'‐carbonitriles	
8a‐c	have	been	obtained	as	crystalline	products	in	yields	up	to	
80%	 where	 a	 spiro‐thiazolidin‐4‐one	 ring	 has	 been	 formed	
(Scheme	 2).	 Apparently,	 the	 reaction	 involves	 a	 nucleophilic	
attack	by	sulpher	atom	of	thioglycolic	acid	on	the	carbon	atom	
of	the	imino	group	to	give	 intermediate	L	through	a	transition	
state	 like	 K.	 Heterocyclization	 of	 L	 with	 an	 elimination	 of	 a	
water	molecule	gave	compounds	8a‐c	(Scheme	2).	
The	 structures	 of	 compounds	 8a‐c	 have	 been	 confirmed	
through	 their	 elemental	 analysis	 and	 spectroscopic	 data.	 For	
example,	 7'‐(4‐amino‐3‐cyano‐5,10‐dioxo‐1,5,10,10a‐tetra	
hydro‐benzo[g]quinolin‐2‐yl)‐3‐(4‐hydroxyphenyl)‐3',4,5'‐
trioxo‐3',5'‐dihydrospiro	 [thiazolidine‐2,2'‐thiazolo[3,2‐a]	
pyrimidine]‐6'‐carbonitrile	 (8b)	 was	 given	 the	 assigned	
structure	due	to	the	following	reasons:	
a)	Elemental	microanalysis	of	compound	8b	corresponds	to	
a	molecular	formula	of	C29H15N7O6S2	(621.60).	
b)	 The	 mass	 spectrum	 of	 compound	 8b	 recorded	 the	
molecular	ion	peak	[M]+	at	m/z	621.	
c)	 Its	 IR	 spectrum	 lacked	 any	 absorption	 due	 to	 the	
exocyclic	C=N	that	appeared	for	6b	at	1645	cm‐1	as	result	of	
addition	on	that	bond.	The	broad	band	appeared	from	3440	
to	3240	is	attributed	to	the	absorption	of	OH,	NH2	and	NH	
groups.	The	spectrum	revealed	also	the	presence	of	bands	
at	 3057,	 3025	 (aromatic	 C‐H),	2940,	2893	 (aliphatic	C‐H),	
2234,	2210	(CN),	1710,	1680	(C=O),	1608	(aromatic	C=C)	
and	1572	(cyclic	C=N).	
d)	 The	 1H	 NMR	 spectrum	 of	8b	 revealed	 the	 presence	 of	
two	doublets	at		3.76	ppm	and	4.03	ppm,	each	with	1,2	JHH	=	
16.0	Hz,	which	are	attributed	to	the	two	chemically	but	not	
magnetically	 equivalent	 geminal	 cyclic	methylene	 protons	
in	the	N‐substituted	thiazolidin‐4‐one	ring.	The	integration	
of	the	multiplet	that	appeared	in	region	7.01‐8.14	ppm	was	
found	to	correspond	to	nine	protons.	Such	multiplet	is	due	
to	 absorption	of	 the	 eight	 aromatic	protons	 in	 addition	 to	
the	 hydroxyl	 group	 proton.	 The	 spectrum	 showed	 also	
bands	 at	 3.61	 (s,	 1H,	 O=C‐CH‐NH),	 6.70	 (s,	 2H,	 NH2,	 D2O‐
exchangeable)	and	10.15	(s,	1H,	NH,	D2O‐exchangeable).	
	
4.	Conclusion	
	
In	 the	 present	 investigation,	 we	 have	 successfully	
synthesized	some	novel	compounds	 incorporating	two	and/or	
three	heterocyclic	moieties	of	anticipated	biological	activities	in	
one	and	the	same	molecule.	Thus,	the	molecule	of	compound	4	
incorporates	 both	 of	 the	 quinoline	 moiety	 as	 well	 as	 the	
thiazoloprymidine	 moiety,	 which	 is	 also	 known	 of	 its	
pharmaceutical	 activity	 [48].	 In	 addition	 to	 the	 two	 latter	
moieties,	compounds	7a‐c	and	8a‐c	incorporate	also	the	spiro‐
β‐lactam	and	the	spiro‐thiazolidin‐4‐one	moieties,	respectively,	
in	 their	 structures.	 On	 the	 other	 hand,	 compounds	 6a‐c	 also	
belong	to	the	class	of	Schiff	bases	that	are	well	known	of	their	
biological	 activities	 [40].	 The	 feasibility	 of	 the	 synthetic	
procedures	and	the	good	yield	of	the	prepared	compounds	are	
also	advantages	for	the	present	study.		
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